Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors

El propósito de este estudio internacional es tratar de predecir qué pacientes son más propensos a desarrollar efectos adversos tras la radioterapia

News

REQUITE on Facebook

REQUITE patient participation event in Leicester

a REQUITE patient feedback event has been organised in Leicester on May 10th 2018. Patients who participated in the REQUITE observational study in Leicester, their friends and family were invited to attend an evening of talks and discussion about the project and also a newsletter was enclosed on the progress of the study for those who could not make it. 150 Patients and partners registered to attend, a mix of breast and prostate patients.

A new study published yesterday has found a way to identify men with locally advanced prostate cancer who are less likely to respond well to radiotherapy.

Led by Professor Catharine West, REQUITE's co-ordinator, The University of Manchester team created a method of selecting prostate cancer patients who would benefit from treatments which target oxygen deficient tumours.  The study paves the way for better treatment of prostate cancer. To read the newsitem on  AAAS and EurekAlert! click here.

Final REQUITE Symposium Dissemination Day in Manchester on 18th July 2018!

The Final REQUITE Symposium Dissemination day is taking place in Manchester on 18th July 2018 (9:30-16:15, CityLabs). It will celebrate the successes of REQUITE and feedback to stakeholders on the impact of REQUITE and the availability of the REQUITE resource for future research. We hope to reach a wide audience including REQUITE patients, industry representatives, policy makers, clinicians, leading academic researchers, cancer patient groups and the public.

Older news

Recruitment

Breast
2071
Lung
559
383*
Prostate
1809
* non-REQUITE patients included in our analyses

Events

Annual REQUITE meeting

The first day of the Final REQUITE Symposium (17th July, 8:30-17:30, CityLabs) is open to REQUITE consortium members and invited guests. It will have an operational focus.

Dates: 
Tuesday, 17 July, 2018
Location: 
University of Manchester
Oxford Road
M13 9PL Manchester
United Kingdom
GB

Final REQUITE symposium

The Final REQUITE Symposium Dissemination day, (18th July, 9:30-16:15, CityLabs) will celebrate the successes of REQUITE and feedback to stakeholders on the impact of REQUITE and the availability of the REQUITE resource for future research. (Open to all)

Dates: 
Wednesday, 18 July, 2018
Location: 
University of Manchester
Oxford Road
M13 9PL Manchester
United Kingdom
GB

ESMO2018 Congress: Securing access to optimal cancer care

ESMO is and continues to be a leading force of high-quality oncology education, a platform for immense international visibility for scientific research, and a proud contributor to continuous improvements in patient care.

For more information: website

Dates: 
Friday, 19 October, 2018 to Tuesday, 23 October, 2018
Location: 
Messe Munich
Messegelände
81823 München
Germany
DE

ASTRO 2018

ASTRO’S Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year.

Abstract Submission Site Opens: December 13, 2017
Abstract Submission Site Closes: February 14, 2018

Dates: 
Sunday, 21 October, 2018 to Wednesday, 24 October, 2018
Location: 
Henry B. Gonzalez Convention Center
900 E Market St
TX 78205 San Antonio
United States
US